Bis(2-methylisouronium) sulphate
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
52328-05-9COC(=N)N.COC(=N)N.O=S(=O)(O)OQSCPQKVWSNUJLJ-UHFFFAOYSA-N52328-05-9DTXSID001335769Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (14.3%): Causes skin irritation [Warning Skin corrosion/irritation]
P203, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 7 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 28-07-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/10914
Carbamimidic acid, methyl ester, sulfate (2:1): Does not have an individual approval but may be used under an appropriate group standard
VerwendenO-Methylisourea Hemisulfate was used as a reagent in the preparation of (D,L)-arginine methyl ester analogs which display antiarrhythmic actiivity. It was also used in the synthesis of ethyl [6-methyl-2-methoxy-3-(substituted phenylethanone)-4-(substituted phenyl)]-1,2,3,4-tetrahydropyrimidine-5-carboxylates which display antimicrobial activity towards mycobacterium tuberculosis, staphylococcus aureus and bacillus subtilis at varying conentration ranges.
Wird geladen…